Suboptimal Responders to Adefovir Switching to Entecavir

NCT00718887 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Entecavir
DRUG: Adefovir/Entecavir

Sponsor

Bristol-Myers Squibb